Opening the KV3.1 gates: A therapeutic strategy for progressive myoclonus epilepsy type 7?

被引：0
|
作者：
Gandini, Maria A. [1 ]
Zamponi, Gerald W. [1 ]
机构：
[1] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
来源：
CELL REPORTS MEDICINE | 2024年 / 5卷 / 02期
关键词：
ATAXIA;
D O I：
10.1016/j.xcrm.2024.101425
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Progressive myoclonus epilepsy type 7, a debilitating neurological disorder, is caused by a loss -of -function mutation in the KV3.1 channel. Exciting work by Feng et al.1 utilizes a new knockin mouse model to identify a potential therapeutic intervention.
引用
收藏
页数：2
相关论文
共 50 条
  • [31] THE GENE FOR PROGRESSIVE MYOCLONUS EPILEPSY OF THE LAFORA TYPE MAPS TO CHROMOSOME 6Q
    SERRATOSA, JM
    DELGADOESCUETA, AV
    POSADA, I
    SHIH, S
    DRURY, I
    BERCIANO, J
    ZABALA, JA
    ANTUNEZ, MC
    SPARKES, RS
    HUMAN MOLECULAR GENETICS, 1995, 4 (09) : 1657 - 1663
  • [32] Progressive Myoclonus Epilepsy Caused by a Homozygous Splicing Variant of SLC7A6OS
    Mazzola, Laure
    Oliver, Karen L.
    Labalme, Audrey
    Baykan, Betul
    Muona, Mikko
    Joensuu, Tarja H.
    Courage, Carolina
    Chatron, Nicolas
    Borsani, Giuseppe
    Alix, Eudeline
    Ramond, Francis
    Touraine, Renaud
    Bahlo, Melanie
    Bebek, Nerses
    Berkovic, Samuel F.
    Lehesjoki, Anna-Elina
    Lesca, Gaetan
    ANNALS OF NEUROLOGY, 2021, 89 (02) : 402 - 407
  • [33] Effects of n-acetylcysteine on progressive myoclonus epilepsy of unverricht-lundborg type.
    Kazibutowska, ZK
    Motta, E
    Bal, A
    Golba, A
    Warakomski, P
    Wielkoszynski, T
    EPILEPSIA, 2004, 45 : 158 - 159
  • [34] LINKAGE STUDIES IN PROGRESSIVE MYOCLONUS EPILEPSY OF UNVERRICHT-LUNDBORG TYPE (EPM1)
    LEHESJOKI, AE
    KOSKINIEMI, M
    SISTONEN, P
    NORIO, R
    DELACHAPELLE, A
    CYTOGENETICS AND CELL GENETICS, 1991, 58 (3-4): : 2037 - 2037
  • [35] Progressive myoclonus epilepsy and ceroidolipofuscinosis 14: The multifaceted phenotypic spectrum of KCTD7-related disorders
    Mastrangelo, Mario
    Sartori, Stefano
    Simonati, Alessandro
    Brinciotti, Mario
    Moro, Francesca
    Nosadini, Margherita
    Pezzini, Francesco
    Doccini, Stefano
    Santorelli, Filippo Maria
    Leuzzi, Vincenzo
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2019, 62 (12)
  • [36] Limitations of the UMRS for the evaluation of progression of myoclonus in progressive myoclonus epilepsy type 1 (EPM1) in the prospective follow-up
    Hypponen, Jelena
    Silvennoinen, Katri
    Saisanen, Laura
    Rissanen, Saara
    Karjalainen, Pasi
    Mervaala, Esa
    Kalviainen, Reetta K.
    EPILEPSIA, 2021, 62 : 73 - 74
  • [37] Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine
    Hurd, RW
    Wilder, BJ
    Helveston, WR
    Uthman, BM
    NEUROLOGY, 1996, 47 (05) : 1264 - 1268
  • [38] Altered cortical inhibition in Unverricht-Lundborg type progressive myoclonus epilepsy (EPM1)
    Danner, Nils
    Julkunen, Petro
    Khyuppenen, Jelena
    Hukkanen, Taina
    Kononen, Mervi
    Saisanen, Laura
    Koskenkorva, Paivi
    Vanninen, Ritva
    Lehesjoki, Anna-Elina
    Kalviainen, Reetta
    Mervaala, Esa
    EPILEPSY RESEARCH, 2009, 85 (01) : 81 - 88
  • [39] Lack of activation of human secondary somatosensory cortex in Unverricht-Lundborg type of progressive myoclonus epilepsy
    Forss, N
    Silén, T
    Karjalainen, T
    ANNALS OF NEUROLOGY, 2001, 49 (01) : 90 - 97
  • [40] CSTB gene replacement improves neuroinflammation, neurodegeneration and ataxia in murine type 1 progressive myoclonus epilepsy
    Emrah Gumusgoz
    Sahba Kasiri
    Mayank Verma
    Jun Wu
    Daniel Villarreal Acha
    Ummay Marriam
    Sharyl Fyffe-Maricich
    Amy Lin
    Xin Chen
    Steven J. Gray
    Berge A. Minassian
    Gene Therapy, 2024, 31 : 234 - 241
12345